Healthcare

Image

Europe Drug Safety Solutions and Pharmacovigilance Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Jun 2023
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Europe Drug Safety Solutions and Pharmacovigilance Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 49.75 Million
Diagram Market Size (Forecast Year) USD 86.13 Million
Diagram CAGR %

Europe Drug Safety Solutions and Pharmacovigilance Market, By Type (Software, Services), Product (Standard Form, Customized Form), Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software), Delivery (On-Premise Delivery Mode, On-Demand/Cloud-Based (SAAS) Delivery Mode), End Users (Biotechnology and Pharmaceuticals, Contract Research Organizations (CROS), Hospitals, KPOs/BPOs, Healthcare Providers), Distribution Channel (Direct Sales, Retail Sales) – Industry Trends and Forecast to 2030.

Europe Drug Safety Solutions and Pharmacovigilance Market Analysis and Size

The rising prevalence of adverse drug reactions (ADRs) is the primary driver of the drug safety solutions and pharmacovigilance market. Furthermore, the increasing adoption of pharmacovigilance software by outsourcing companies and strict government regulations for drugs prior to and post-commercialization contribute to the market's overall growth. The market is expected to benefit from research collaborations and partnerships, as well as drug safety solutions and pharmacovigilance automation, which aid in achieving more effective and durable mechanical hemostasis.                                

Data Bridge Market Research analyses that the Drug Safety Solutions and Pharmacovigilance s market which was USD 49.75 million in 2022, would rocket up to USD 86.13 million by 2030, and is expected to undergo a CAGR of 7.10% during the forecast period. This indicates that the market value. “Software” dominates the type segment of the Drug Safety Solutions and Pharmacovigilance market owing to the rise in technological advancement. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Europe Drug Safety Solutions and Pharmacovigilance Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Software, Services), Product (Standard Form, Customized Form), Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software), Delivery (On-Premise Delivery Mode, On-Demand/Cloud-Based (SAAS) Delivery Mode), End Users (Biotechnology and Pharmaceuticals, Contract Research Organizations (CROS), Hospitals, KPOs/BPOs, Healthcare Providers), Distribution Channel (Direct Sales, Retail Sales)

Countries Covered

Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe.

Market Players Covered

PPD Inc( U.S.), Drug Safety Solutions Limited (U.S.), C3i (U.S.), Worldwide Clinical Trials (U.S.), Bioclinica (U.S.), Ennov (Hong Kong), AB Cube S.A.S. (France), Labcorp Drug Development (U.S.), Accenture (Ireland), ICON plc (U.S.), Ergomed plc (U.K.), Genpact (U.S.), Cognizant (U.S.), Parexel International Corporation (U.S.), ArisGlobal (U.S.), Oracle Corporation,(U.S.), Sparta Systems(U.S.), EXTEDO(Germany), Veeva Systems(U.S.)

Market Opportunities

  • Strategic initiatives by key market players
  • Rise in technological advancement
  • Expansion of pharmacovigilance in emerging market

Market Definition

Drug safety and pharmacovigilance (PV or PHV) is a scientific procedure for collecting, analyzing, monitoring, and preventing adverse effects in drugs and therapies. Its primary goal is to ensure that pharmaceutical developers meet industry regulatory standards, and it puts additional pressure on biotechnology and pharmaceutical companies to manufacture safe drugs and evaluate their post-sales results.

Europe Drug Safety Solutions and Pharmacovigilance Market Dynamics

Drivers

  • Patient-Centric Approach:

There is a growing emphasis on patient safety and engagement in healthcare. Patients are becoming active participants in monitoring and reporting adverse events associated with drug usage. Drug safety solutions are being designed to facilitate patient-centric pharmacovigilance, allowing patients to report their experiences directly and contribute to the safety monitoring process...

  • Growing Adverse Drug Reactions (ADRs)

Adverse drug reactions refer to unwanted or harmful reactions that occur as a result of drug usage. The increasing occurrence of ADRs has heightened the importance of pharmacovigilance. Drug safety solutions enable the early detection, assessment, and reporting of ADRs, facilitating the mitigation of risks associated with drug usage.

Opportunities

  • Expansion of Pharmacovigilance in Emerging Markets

The globalization of the pharmaceutical industry has led to increased clinical trial activity and drug distribution in emerging markets. This expansion presents opportunities for drug safety solutions and pharmacovigilance providers to offer their services in these regions. Emerging markets often have unique regulatory requirements and a need for localized expertise, creating opportunities for companies to provide tailored pharmacovigilance solutions.

Restraints/Challenges

  • Regulatory Compliance Challenges

The pharmacovigilance field is subject to strict regulations and guidelines imposed by regulatory authorities globally. Keeping up with evolving regulatory requirements and ensuring compliance can be challenging. Companies must continuously adapt their systems and processes to meet changing regulatory standards, which may require additional resources and expertise.

Data Quality and Standardization

Pharmacovigilance relies heavily on the collection and analysis of vast amounts of safety data. However, data quality and standardization can vary, making it challenging to extract meaningful insights. Incomplete, inaccurate, or inconsistent data can impact the effectiveness of drug safety solutions and hinder the identification of potential adverse events or safety signals.

This drug safety solutions and pharmacovigilance market report provide details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Drug Safety Solutions and Pharmacovigilance market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.

Recent Developments

  • In 2019, The Laboratory Corporation of America Health EC and The New Jersey announced a collaboration and the development of a database and information exchange platform. This platform will be beneficial in conjunction with LabCorp's Care Intelligence application. This collaboration will result in better lives and health for LabCorp employees. This will result in increased patient satisfaction and recognition
  • In 2019, Parexel International Corporation announced that they had formed a strategic partnership with Datavant, Inc. to connect real-world data, including all clinical trials conducted by Parexel. This collaboration will broaden and extend the company's entire portfolio, making data linking available to more customers

Europe Drug Safety Solutions and Pharmacovigilance Market Scope

The drug safety solutions and pharmacovigilance market is segmented on the basis of type, product, functionality, end user, delivery, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Software
  • Services

 Product

  • Standard Form
  • Customized Form

Functionality

  • Adverse Event Reporting Software
  • Drug Safety Audits Software
  • Issue Tracking Software

 Delivery

  • On-Premise Delivery Mode
  • On-Demand/Cloud-Based (SAAS) Delivery Mode

 End Users

  • Biotechnology and Pharmaceuticals
  • Contract Research Organizations (CROS)
  • Hospitals
  • KPOs/BPOs
  • Healthcare Providers

 Distribution Channel

  • Direct Sales
  • Retail Sales

Europe Drug Safety Solutions and Pharmacovigilance Market Regional Analysis/Insights

The drug safety solutions and pharmacovigilance market is analyzed, and market size insights and trends are provided by country, type, product, functionality, end user, delivery, and distribution channel as referenced above.

The countries covered in the Drug Safety Solutions and Pharmacovigilance market report are Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, the Rest of Europe.

Germany dominates the Drug Safety Solutions and Pharmacovigilance market because of the strong base of healthcare facilities, the strong presence of major players in the market, and rising number of research activities in this region.   

Germany is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, growing research activities in the region, availability of massive untapped markets, a large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The Drug Safety Solutions and Pharmacovigilance s market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the Drug Safety Solutions and Pharmacovigilance s market, the impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Drug Safety Solutions and Pharmacovigilance market. The data is available for the historical period 2012-2022.

Competitive Landscape and Drug Safety Solutions and Pharmacovigilance s Market Share Analysis

The Drug Safety Solutions and Pharmacovigilance market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to Drug Safety Solutions and Pharmacovigilance s market.

Some of the major players operating in the drug safety solutions and pharmacovigilance s market are:

  • PPD Inc (U.S.)
  • Drug Safety Solutions Limited (U.S.)
  • C3i (U.S.)
  • Worldwide Clinical Trials (U.S.)
  • Bioclinica (U.S.)
  • Ennov (Hong Kong)
  • AB Cube S.A.S. (France)
  • Labcorp Drug Development (U.S.)
  • Accenture (Ireland)
  • ICON plc (U.S.)
  • Ergomed plc (U.K.)
  • IQVIA (U.S.)
  • Genpact (U.S.)
  • Cognizant (U.S.)
  • Parexel International Corporation (U.S.)
  • ArisGlobal (U.S.)
  • Oracle Corporation,(U.S.)
  •  Sparta Systems(U.S.)
  •  EXTEDO(Germany)
  •  Veeva Systems(U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Drug Safety Solutions and Pharmacovigilance s market value was USD 49.75 million in 2022
The Drug Safety Solutions and Pharmacovigilance s market is projected to grow at a CAGR of 7.10% during the forecast period of 2023-2030.
The drug safety solutions and pharmacovigilance market is segmented on the basis of type, product, functionality, end user, delivery, and distribution channel.
The countries covered in the Drug Safety Solutions and Pharmacovigilance market report are Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, the Rest of Europe
Germany dominates the Drug Safety Solutions and Pharmacovigilance market because of the strong base of healthcare facilities, the strong presence of major players in the market, and rising number of research activities in this region.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials